申请人:Hoechst Aktiengesellschaft
公开号:US05567734A1
公开(公告)日:1996-10-22
Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, of the formula I ##STR1## are described where R(A) and R(B) are H, Hal, CN, OR(6), alkyl, O.sub.r -perfluoroalkyl or NR(7)R(8); R(6) is hydrogen, (cyclo)alk(en)yl, perfluoroalkyl, phenyl or benzyl; R(7) and R(8) are defined as R(6); X is 1-3; R(1) is H, alkyl or --O.sub.0-1 (CH.sub.2)O.sub.0-1 perfluoroalkyl; R(2), R(3), R(4) and R(5) are defined as R(1), with the condition, however, that R(1), R(2), R(3), R(4) and R(5) are not simultaneously hydrogen and that R(1), R(2), R(3), R(4) and R(5) can only be alkyl when at least one of the substituents R(A) or R(B) contains a O.sub.r (CH.sub.2).sub.a C.sub.b F.sub.2b+1 group; as are the pharmaceutically acceptable salts thereof. Methods of preparation of compounds of formula I are also described.
描述了携带全氟烷基的苯基取代烷基氨基甲酰胍衍生物,其化学式为I ##STR1## 其中R(A)和R(B)为H、Hal、CN、OR(6)、烷基、O.sub.r-全氟烷基或NR(7)R(8);R(6)为氢、(环)烷(烯)基、全氟烷基、苯基或苄基;R(7)和R(8)被定义为R(6);X为1-3;R(1)为H、烷基或--O.sub.0-1(CH.sub.2)O.sub.0-1全氟烷基;R(2)、R(3)、R(4)和R(5)被定义为R(1),但条件是R(1)、R(2)、R(3)、R(4)和R(5)不同时为氢,并且当至少一个取代基R(A)或R(B)含有O.sub.r(CH.sub.2).sub.aC.sub.bF.sub.2b+1基团时,R(1)、R(2)、R(3)、R(4)和R(5)只能是烷基;其药学上可接受的盐也属于此类。还描述了化合物I的制备方法。